融捷健康(300247.SZ)：安徽证监局对公司采取责令改正措施

Core Viewpoint - Rongjie Health (300247.SZ) has been ordered by the Anhui Regulatory Bureau of the China Securities Regulatory Commission to rectify its operations due to several violations, including improper accounting practices and inaccurate information disclosure. Group 1: Accounting Issues - The company has been found to have non-compliant accounting practices, with revenue from major product sales recognized at the point of shipment, inconsistent with the revenue recognition policy disclosed in the annual report [1] - The consolidated financial statements failed to write off the revaluation surplus of investment properties held by subsidiaries, resulting in an inflated "Investment Properties" account by 2.2509 million yuan for the years 2022-2024 [1] Group 2: Information Disclosure Issues - The 2024 annual report and financial statement notes contain multiple errors and omissions, including inconsistencies in the amounts disclosed for "assets and liabilities measured at fair value" [1] - The reduction in the book value of "Fixed Assets - Office and Other Equipment" was less than the reduction in accumulated depreciation for the current period [1] - Inaccuracies were noted in the disclosure of "foreign currency monetary items" and the failure to disclose changes in accounting estimates for "other receivables" as required [1][2] Group 3: Fundraising Issues - The company has been cited for improper use of raised funds and inaccuracies in the disclosure of fundraising information [2]